MAYZENT
Live / Registered — Registered — international registration renewed (as of 03 Feb 2026)
What this means for you
Registered since 17 Mar 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79261592
- Registration number
- 6010378
- Mark type
- Design + words
- Filed
- 03 May 2019
- Published for opposition
- 31 Dec 2019
- Registered
- 17 Mar 2020
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: [ Anti-infectives; ] anti-inflammatories; [ antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; ] pharmaceutical preparations acting on the central nervous system; [ pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; ] pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, [ the endocrine system, ] the musculo-skeletal system [ and the genitourinary system ] ; [ pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; ] pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders [ ; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma ]
Owner
- NOVARTIS AG, CH
- NOVARTIS AG, CH
- NOVARTIS AG, Basel, CH
Prosecution history
- 03 Feb 2026 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
- 03 Feb 2026 — REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
- 26 Jan 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 16 Sept 2025 — TEAS SECTION 71 & 15 RECEIVED
- 17 Mar 2025 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 07 Aug 2020 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 23 Jul 2020 — FINAL DISPOSITION NOTICE SENT TO IB
- 23 Jul 2020 — FINAL DISPOSITION PROCESSED
- 17 Jun 2020 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 17 Mar 2020 — REGISTERED-PRINCIPAL REGISTER
- 04 Jan 2020 — NOTIFICATION PROCESSED BY IB
- 31 Dec 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 31 Dec 2019 — PUBLISHED FOR OPPOSITION
- 18 Dec 2019 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 18 Dec 2019 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB